Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "GenScript"

3 News Found

GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership
Biotech | March 16, 2026

GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership

GenScript wins Best CDMO award for the third time
News | March 30, 2022

GenScript wins Best CDMO award for the third time

The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".

SK bioscience appoints new executives
People | January 23, 2023

SK bioscience appoints new executives

Two biopharmaceutical experts join SK bioscience to strengthen the future strategies

Latest Stories

GSK expands RSV vaccine to younger adults in US, targeting high-risk 18–49 age group

Virta Health shows nutrition therapy may extend life in advanced pancreatic cancer

Aptar Pharma teams up with COVIRIX Medical to explore next-generation antiviral inhaler

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Packaging